Introduction to Therapeutic concepts in Pregnancy Flashcards
Describe the BRAN decision making technique
benefits, risks, alternatives, do nothing
List the critical periods of development and the weeks they occur
All or none weeks 2-4 weeks after last menstrual period, Embryonic period weeks 4-11, fetal period weeks 11-birth
explain the all or none period
first 2 weeks after conception where drug can either result in miscarriage or have no effect
describe the embryonic period
most critical period of fetal development, major malformations can occur as major formation is occurring
describe the fetal period
if drug is taken it will not cause malformations since every is already formed but may cause disruptions of normally formed organs eg deafness
what is the baseline risk of congenital abnormalities in pregnancy?
3-5%
describe the different types of defects that can occur
major: cause significant medical problems possibly requiring surgery or treatment
minor: not significant and not requiring surgery or treatment
functional: changes how part of the body works but not how it looks
List the influencing factors of a drug’s possibility of causing harm
dose, route of exposure, pharmagenomics, how much is transferred across placenta
List the characteristics of teratogens
produce deformities in >2-3%, produce consistent pattern of deformities
Describe category A for Medications
safe for pregnancy
Describe category B for Medications
B1: limited women, animal studies have shown no evidence of AE
B2: limited women, limited animal studies but available data shows no AE
B3: limited women, animal studies have shown evidence of AE, significance uncertain in humans
Describe category C for Medications
C: suspected to have caused harmful effects without malformations, may be reversible
Describe category D for Medications
D: suspected or expected to cause malformation with irreversible damage
Describe category X for Medications
X: high risk causing permanent damage to fetus and should not be used in pregnancy
Explain the considerations when referring to medication categories for pregnancy
the categories are simplistic and not hierarchical, not a scale of risk and same category does not mean same risk, no consideration for trimester/critical stage of development when drug is taken, no consideration for context of med use or route of administration, information not updated over time in some resources